25 completed, 2 terminated, 2 unknown, 1 active not recruiting. 11 Phase 2, 9 Phase 3, 5 Not applicable, 5 Phase 4, 2 Phase 1.
Follow Nicoderm: new trials by email Literature Review of Nicoderm trials Research Report on Nicoderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Completed | Rose Research Center, LLC | 150 | 2024-08-29 | 2026-02-06 |
| Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Terminated | Rose Research Center, LLC | 4 | 2023-12-27 | 2025-03-30 |
| Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia Nicotine patch, text messaging - Nicotine Dependence, Tobacco Dependence | Phase 1 | Unknown | University of Southern California | 800 | 2023-09-13 | 2023-11-28 |
| Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada Nicotine patch - Tobacco Use Cessation | Phase 4 | Completed | Centre for Addiction and Mental Health | 498 | 2020-11-23 | 2023-01-18 |
| Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates Nicotine patch - Tobacco Use Cessation | Completed | Centre for Addiction and Mental Health | 123 | 2020-10-19 | 2021-08-31 | |
| Optimizing Tobacco Use Treatment for PLWHA Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence | Phase 3 | Active not recruiting | Abramson Cancer Center at Penn Medicine | 340 | 2020-02-17 | 2026-09-04 |
| Individualizing Pharmacotherapy for African American Smokers Nicotine patch, Varenicline Tartrate, Bupropion - Smoking Cessation | Phase 3 | Completed | University of Kansas Medical Center | 392 | 2019-05-01 | 2023-04-03 |
| The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Nicotine patch, Placebo patch, E-cigarettes - Nicotine Dependence, Cigarettes | Phase 2 | Completed | Duke University | 94 | 2018-08-06 | 2023-02-08 |
| Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment Nicotine patch, ENDS, Placebo patch - Nicotine Dependence | Phase 2 | Withdrawn | Duke University | 2018-07-01 | 2018-09-12 | |
| Personalized Dosing of Nicotine Replacement (NRT to Effect) Nicotine Patch, Placebos - Tobacco Use Disorder, Nicotine Dependence | Phase 4 | Completed | Centre for Addiction and Mental Health | 211 | 2018-01-23 | 2024-01-29 |
| Combination Nicotine Patch / Lorcaserin for Smoking Cessation lorcaserin, nicotine patch, placebo lorcaserin - Nicotine Dependence | Phase 2 | Completed | Duke University | 97 | 2016-11-08 | 2019-05-07 |
| Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence | Phase 2 / Phase 3 | Terminated | Centre for Addiction and Mental Health | 18 | 2015-07-01 | 2018-07-19 |
| Mobile Contingency Management for Smoking Cessation in Returning US Veterans Nicotine gum, mobile contingency management, Telephone counseling - Smoking, Veterans | Not applicable | Completed | Duke University | 291 | 2015-01-01 | 2020-02-21 |
| Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers Nicotine Patches, mobile contingency management (mCM), Smoking cessation counseling - Tobacco Use Disorder, Homelessness | Phase 4 | Completed | VA Office of Research and Development | 133 | 2014-10-01 | 2022-01-04 |
| The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers Nicotine Replacement Therapy (NRT), Varenicline, HIV Tailored Quit Smoking Counseling - HIV, Smoking Cessation | Phase 3 | Unknown | Ottawa Hospital Research Institute | 256 | 2014-01-01 | 2015-12-14 |
| Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers Nicotine Patch, Moclobemide - Nicotine Dependence | Phase 2 | Completed | Jed E. Rose | 76 | 2013-09-01 | 2017-08-23 |
| Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate Ganaxolone, Nicotine Patch - Smoking Cessation | Phase 2 | Completed | Jed E. Rose | 36 | 2013-06-01 | 2014-09-08 |
| Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers Nicotine replacement therapy - Smoking | Phase 4 | Completed | Centre for Addiction and Mental Health | 1000 | 2012-05-01 | 2015-10-16 |
| Meclizine as a Potential Smoking Cessation Treatment Meclizine, Nicotine Patch, Placebo - Smoking Cessation | Phase 2 | Completed | Duke University | 146 | 2011-08-01 | 2014-08-01 |
| Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation Varenicline, Bupropion, Nicotine patches - Nicotine Dependence | Phase 3 | Completed | Duke University | 282 | 2011-07-01 | 2017-11-14 |
Showing 20 of 31. Sign in to see all of them.
Smoking Cessation (20) · Tobacco Use Disorder (16) · Cigarette Smoking (7) · Smoking (6) · Tobacco Use Cessation (3) · Harm Reduction (2) · Vaping (2) · Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Tobacco Use (1)
Centre for Addiction and Mental Health (7) · Duke University (7) · Jed E. Rose (2) · Rose Research Center, LLC (2) · Abramson Cancer Center at Penn Medicine (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · National Institute on Drug Abuse (NIDA) (1) · Ottawa Heart Institute Research Corporation (1) · Ottawa Hospital Research Institute (1) · UConn Health (1) · University of California, San Francisco (1) · University of Connecticut (1) · University of Kansas Medical Center (1) · University of Minnesota (1) · University of Pennsylvania (1)
United States (20) · Canada (10) · Uganda (1) · Zambia (1)
Jed E Rose, Ph.D. (5) · Jed E. Rose, Ph.D. (2) · Laurie Zawertailo, PhD (2) · Peter Selby, MBBS (2) · Andrew Pipe, MD (1) · Cheryl A Oncken, MD (1) · Cunningham John, PhD (1) · Dorothy Hatsukami, Ph.D. (1) · Dorothy Hatsukami, PhD (1) · F. Joseph McClernon, Ph.D. (1) · James M Davis, M.D. (1) · Jean C Beckham, PhD (1) · John A Cunningham, PhD (1) · John Cunningham, PhD (1) · Louise Balfour, PhD (1)
PMID 34611902, PMID 37142273, PMID 12745503, PMID 19339135, PMID 20124230, PMID 21955930, PMID 22218402, PMID 23801018, PMID 23963055, PMID 24057996, PMID 24075893, PMID 24934962, PMID 25361769, PMID 25695576, PMID 26809849, PMID 27543563, PMID 28693456, PMID 28720080, PMID 31589323, PMID 32600406, PMID 33228625, PMID 34007899, PMID 36264570, PMID 36387983, PMID 37230961, PMID 37335995, PMID 37338906, PMID 37486633, PMID 38243301, PMID 39976595, PMID 40074264, PMID 40684230, PMID 41593728
P50DA027840 (7), K24AA013736 (1), M01RR006192 (1), R01CA243914 (1), R01DA014404 (1), R01DA015365 (1), R01DA046576 (1), U01CA261624 (1)